ctrl K

Watchlist Price Alert

Structure Therapeutics In... (GPCR)

NASDAQ: GPCR · Real-Time Price · USD

20.62

-1.06 (-4.89%)

At close: Jun 16, 2025, 3:59 PM

20.91

1.41%

Pre-market: Jun 17, 2025, 05:44 AM EDT

Structure Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	949.17K	623.26K	266.35K	20.03K
Gross Profit	n/a	-949.17K	-623.26K	-266.35K	-20.03K
Operating Income	-158.23M	-102.78M	-52.56M	-37.7K	-15.91K
Interest Income	n/a	13.38M	1.26M	122.00	168.29K
Pretax Income	-122.22M	-89.38M	-51.3M	-37.82K	-15.74K
Net Income	-122.53M	-89.62M	-51.32M	-38.05K	-15.88K
Selling & General & Admin	49.41M	32.67M	16.37M	8.59K	3.54K
Research & Development	108.81M	70.1M	36.19M	29.11K	12.36K
Other Expenses	n/a	0.00	n/a	n/a	n/a
Operating Expenses	158.23M	102.78M	52.56M	37.7K	15.91K
Interest Expense	n/a	13.39M	n/a	122.16K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	102.78M	52.56M	37.7K	15.91K
Income Tax Expense	310K	236K	17K	231.00	138.00
Shares Outstanding (Basic)	52.64M	36.73M	36.59M	36.59M	36.59M
Shares Outstanding (Diluted)	52.64M	36.73M	36.59M	36.59M	36.59M
EPS (Basic)	-2.33	-2.44	-1.44	-1.2	-0.44
EPS (Diluted)	-2.33	-2.44	-1.44	-1.2	-0.44
EBITDA	-158.23M	-102.46M	-52.28M	-37.62M	-15.75M
EBIT	n/a	-102.78M	-52.56M	-37.75M	-15.77M
Depreciation & Amortization	n/a	316K	623.26K	266.35K	20.03K